RKLB Stock Edges Up Overnight: Neutron’s Second Stage Heads To Launch Site — Analyst Eyes Q2 2027 Debut And Shares Doubling

  • Rocket Lab shipped Neutron hardware toward its Virginia launch site.

  • The second stage and thrust module are headed to Wallops for launch-pad systems testing.

  • Electron recently completed its 98th mission, deploying three HawkEye 360 satellites on Rocket Lab’s 19th launch of 2026.

Rocket Lab (RKLB) shares rose 0.3% overnight heading into Tuesday after the company shipped Neutron’s second-stage hardware to its Virginia launch site, while Cantor Fitzgerald forecast a Q2 2027 debut and reiterated a price target implying shares could more than double.

RKLB stock jumped 2% to $53.82 on Monday, logging its second straight session of gains.

See what 10M+ investors are talking about. Get the Stocktwits Daily Rip for what retail is watching right now, free to your inbox

Neutron Takes Its Next Step Toward Launch

Rocket Lab said on X that Neutron’s second stage — the upper section that will deliver payloads into orbit — and its thrust module had left the factory aboard a barge bound for Launch Complex 3 at Wallops Island in Virginia.

“Earlier today we sent Neutron’s Stage 2 and Thrust Module out of the Neutron Factory and onto a barge for transport through Chesapeake Bay to Wallops Island in Virginia,” the company said.

Once it arrives, the thrust module will be placed directly onto the launch mount, the structure that supports the rocket at the pad. Engineers will test its fluid-handling systems and check the connections between the module and the mount.

These checks are important for Neutron’s design. Instead of using a traditional strongback structure to help support the rocket, Neutron’s only physical connection to the pad runs through its thrust module. Testing that connection now lets engineers check how the hardware and ground systems work together before the full rocket is assembled.

The shipment follows an earlier update showing the second-stage tank assembly being turned from vertical to horizontal in preparation for the journey.

Cantor Eyes 127% Upside For RKLB Stock

Cantor Fitzgerald reiterated its ‘Overweight’ rating and $122 price target following Rocket Lab’s latest Electron launch. The target implies a 127% upside from Monday’s close. The brokerage expects Neutron’s first launch in the second quarter of 2027.

Rocket Lab has given a broader 2027 outlook and plans to announce a more precise date after completing further manufacturing and testing milestones. Neutron is key to Rocket Lab’s expansion into larger commercial satellite deployments, government missions and national-security launches, extending its reach beyond Electron’s small-launch business.

Source link

Visited 1 times, 1 visit(s) today

Related Article

Should You Buy Markel Stock (MKL) on the Dip?

Shares of Markel (NYSE: MKL) were down 13% year-to-date as of Oct. 23. That could make an investor wonder: Is this a good time to buy into Markel? Here’s my take. For starters, know that Markel has long been referred to as a “mini-Berkshire” because of similarities to Warren Buffett’s Berkshire Hathaway. But there are

XP (XP) Stock Still Appears Undervalued After the 48% Slide

XP Inc. has just seen a sharp share price reset, and the question now is whether the current market value lines up with the returns it earns on its capital. After a politically charged selloff in Brazil, investors are weighing if the business performance behind XP stock justifies where the price has landed. The share

Is COVER Corporation (TSE:5253) Potentially Undervalued?

While COVER Corporation (TSE:5253) might not have the largest market cap around , it saw a decent share price growth of 12% on the TSE over the last few months. The recent rally in share prices has nudged the company in the right direction, though it still falls short of its yearly peak. With many

Wall Street’s Blockbuster Stock Split Was Just Announced, and It’s Anything but Conventional

Although artificial intelligence (AI) has been the hottest thing since sliced bread, it’s not the only trend responsible for lifting the stock market to new heights. Investors gravitating toward Wall Street’s premier stock-split stocks have also played a key role in the market’s outperformance. Several high-profile stock splits have been announced this year, including cybersecurity

The markets are starting to act seriously weird. Blame AI

On the surface, the markets seem stable. Stocks are near record highs, and bonds are right about where they’ve been for the past couple of months. But check under the hood, and you’ll see signs that investors are growing increasingly nervous — mostly because of AI. This time, the anxiety isn’t because AI is going

This warning sign suggests more tech stock poundings could be in the cards

The tech trade could have some sharper down days ahead if the red flags in the bond market are to be believed. Hyperscaler credit default swaps continue to widen, BTIG strategist Jonathan Krinsky pointed out. Investment-grade tech credit default swaps are now the widest they’ve been since 2022. Yet, the S&P Tech Sector is just

The 10 biggest stocks are faltering, and it’s dragging the S&P 500 down

Apple (AAPL) and Nvidia (NVDA) may be renewing their battle for the world’s most valuable company, but a challenging few months for the S&P 500’s (^GSPC) 10 largest companies are holding back the broader index. The 10 biggest stocks in the S&P 500 have started to falter again relative to the rest of the market,

5 Stocks to Buy Trading at Big Discounts

Key Takeaways What’s behind the artificial intelligence selloff and rally in Treasury bonds. Expectations for the October Federal Reserve meeting. What to watch in upcoming earnings from Alphabet GOOG/GOOGL, Microsoft MSFT, and Amazon.com AMZN. Is Hasbro HAS still a buy after earnings? What slowing growth at Netflix NFLX means for the stock. How to incorporate

Lycia leaps onto Nasdaq with upsized $318M IPO as Windward breezes toward listing

Lycia Therapeutics went public with an upsized $317.5 million IPO on Friday, while immunology-focused Windward Bio has also seen which way the public markets are blowing. South San Francisco-based Lycia offered 17.6 million shares as part of its Friday listing—above the 14.7 million shares that the company had previously expected. At $18 apiece, the shares

Prediction: This Magnificent Seven Stock Could Be a $1 Trillion Opportunity

Quick Read Alphabet (GOOG) earns a BUY with a $423.95 price target as Google Cloud grew 82% and its backlog hit $514 billion. Alphabet trades at just 13x trailing earnings versus Microsoft (MSFT) at 29x and Meta (META) at 24x, while growing revenue faster than both. Just released. Our analysts combed the entire stock market

Capital markets expected to mobilise over $386 billion for 2026–2030 growth

A trader talks to a customer in the trading room of a securities firm in Hà Nội. — VNA/VNS Photo HÀ NỘI — The capital markets are expected to provide around VNĐ10 quadrillion (US$386.5 billion) towards meeting the country’s investment needs during 2026–2030, as the Government targets annual economic growth of at least 10 per

How Sam Altman, ChatGPT and AI-Driven Cyberattacks are influencing the Stock Markets

Artificial intelligence is transforming cybersecurity, but it is also creating new risks for businesses, governments and financial markets. Under Sam Altman’s leadership, OpenAI has helped bring advanced AI tools into mainstream use through ChatGPT. However, as AI systems become increasingly capable of identifying software vulnerabilities and executing complex tasks, concerns about cyberattacks are beginning to

Aktsiaselts Infortar own share acquisition transactions

Aktsiaselts Infortar acquired its own shares on the Nasdaq Tallinn Stock Exchange during the period of 19 October – 23 October 2026 as follows: Date Aggregated volume (pcs) Weighted average price per day (EUR) 19.10.2026 195 65,0154 20.10.2026 242 65,3025 21.10.2026 240 68,9167 22.10.2026 244 68,6459 23.10.2026 246 67,8407 Aktsiaselts Infortar is acquiring its own shares

Billionaire Ken Griffin Is Buying This Dividend King That Wall Street Still Rates a Buy

Billionaire Ken Griffin’s Citadel Advisors has been increasing its stake in drugmaker AbbVie (NYSE: ABBV) in recent months. In the second quarter, Citadel purchased 2.7 million shares of AbbVie at an average price of $234.57, for a total investment of about $633 million. That takes Citadel’s stake in AbbVie to 3.2 million shares, worth $909

Why Carpenter Technology Stock Plunged 24.5% This Week

A quarterly revenue report that missed Wall Street expectations sent Carpenter Technology (NYSE:CRS) tumbling 22.5% this week, overshadowing an earnings beat. Carpenter Technology stock changed hands at $292.26 as of the close on Friday, Oct. 23, down 24.5% this week from Friday, Oct. 16’s close, according to data provided by S&P Global Market Intelligence. Over

Scanfil (HLSE:SCANFL) Stock Price Meets Q3 Results With Cash Questions

Scanfil Oyj stock closed at €12.0 on Friday, after a choppy week that left the share down 8.1% over seven days and 3.8% over the past month. The price suggests nerves. The fresh Q3 2026 report tells a different story. Revenue reached €252.2m with net income of €11.6m and earnings per share at €0.18. For

0
Would love your thoughts, please comment.x
()
x